text
"['\n1. 요약재무정보\n가. 요약연결재무정보\n(단위 : 백만원)\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 사업연도구 \xa0분\n제44기\n제43기\n제42기\n[유동자산]\n391,417\n386,120\n411,302\n- 당좌자산\n264,755\n260,713\n311,060\n- 재고자산\n126,662\n125,407\n100,242\n[비유동자산]\n962,818\n867,191\n785,873\n- 유형자산\n779,205\n691,561\n625,128\n- 사용권자산\n7,252\n7,373\n5,710\n- 무형자산\n79,073\n65,952\n66,564\n- 기타비유동자산\n97,288\n102,305\n88,470\n자산총계\n1,354,235\n1,253,311\n1,197,175\n[유동부채]\n266,478\n153,670\n199,712\n[비유동부채]\n161,974\n247,144\n229,593\n부채총계\n428,452\n400,814\n429,305\n[자본금]\n56,676\n56,676\n56,676\n[자본잉여금]\n30,012\n30,012\n30,012\n[기타자본구성요소]\n(45,324)\n(47,755)\n11,801\n[기타포괄손익누계액]\n(9,369)\n(9,348)\n(5,107)\n[이익잉여금]\n797,879\n733,897\n595,858\n[비지배지분]\n95,909\n89,015\n78,630\n자본총계\n925,783\n852,497\n767,870\n종속ㆍ관계ㆍ공동기업 투자주식의 평가방법\n원가법\n원가법\n원가법\n(2023.01.01~2023.09.30)\n(2022.01.01~2022.12.31)\n(2021.01.01~2021.12.31)\n매출액\n580,178\n885,471\n768,688\n영업이익\n103,123\n185,990\n197,685\n당기순이익\n90,060\n166,978\n158,671\n지배회사지분순이익\n86,696\n155,127\n148,338\n주당순이익\n\xa0기본주당이익\n7,970원\n14,099원\n13,332원\n\xa0희석주당이익\n7,907원\n14,021원\n13,331원\n연결에 포함된 회사수\n7\n6\n6\n* 당기 중 (주)바이옥스 지분 취득으로 연결대상 종속회사가 증가하였습니다.나. 요약재무정보\n(단위 : 백만원)\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 사업연도구 \xa0분\n제44기\n제43기\n제42기\n[유동자산]\n274,842\n252,085\n310,019\n- 당좌자산\n190,741\n162,584\n236,056\n- 재고자산\n84,101\n89,501\n73,963\n[비유동자산]\n802,880\n716,932\n637,498\n- 유형자산\n656,403\n592,075\n522,522\n- 무형자산\n5,698\n4,287\n4,310\n- 사용권자산\n1,526\n1,670\n1,786\n- 기타비유동자산\n139,253\n118,900\n108,880\n자산총계\n1,077,722\n969,017\n947,517\n[유동부채]\n198,997\n102,165\n164,963\n[비유동부채]\n145,751\n216,524\n173,271\n부채총계\n344,748\n318,689\n338,234\n[자본금]\n56,676\n56,676\n56,676\n[자본잉여금]\n29,928\n29,928\n29,928\n[자본조정]\n(45,279)\n(47,968)\n11,722\n[기타포괄손익누계액]\n(9,548)\n(8,841)\n(8,365)\n[이익잉여금]\n701,197\n620,533\n519,322\n자본총계\n732,974\n650,328\n609,283\n종속ㆍ관계ㆍ공동기업 투자주식의 평가방법\n원가법\n원가법\n원가법\n(2023.01.01~2023.09.30)\n(2022.01.01~2022.12.31)\n(2021.01.01~2021.12.31)\n매출액\n424,082\n637,647\n570,246\n영업이익\n89,742\n145,266\n166,023\n당기순이익\n103,378\n120,840\n130,175\n주당순이익\n\xa0기본주당이익\n9,503원\n10,983원\n11,700원\n\xa0희석주당이익\n9,429원\n10,929원\n11,698원\n']"
